Evidence map›Paper›PMID 34122404›Full record

ArticleFrontiers in immunology2021

Immune Response to

Harini Bagavant, Antonina M Araszkiewicz, Jessica K Ingram, Katarzyna Cizio, Joan T Merrill, Cristina Arriens, Joel M Guthridge, Judith A James, Umesh S Deshmukh

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Observational
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Amyloid-containing biofilms and autoimmunity.Current opinion in structural biology · 2022
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Harini BagavantArthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States.
Antonina M AraszkiewiczArthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States.
Jessica K IngramArthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States.
Katarzyna CizioArthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States.
Joan T MerrillArthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States.
Cristina ArriensArthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States.
Joel M GuthridgeArthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States.
Judith A JamesArthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States.
Umesh S DeshmukhArthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States.
Oklahoma Medical Research Foundation · USUniversity of Oklahoma Health Sciences Center · US

Funding

Tracking and Evaluation CoreU54GM104938 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI PAUL G SPICER · 2013 to 2026
$68.2M
Oklahoma Rheumatic Disease Research Cores Center (Overall Application)P30AR073750 · NIAMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI JUDITH A JAMES · 2018 to 2026
$8.5M
Oklahoma ACE: Molecular Destruction of Autoimmune Disease to Aid Clinical Trail SuccessUM1AI144292 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI JUDITH A JAMES · 2019 to 2026
$3.3M
NIAID NIH HHS UM1 AI144292NIAMS NIH HHS P30 AR073750NIGMS NIH HHS U54 GM104938
6 · The paper itself

Abstract

Interactions between gut microbes and the immune system influence autoimmune disorders like systemic lupus erythematosus (SLE). Recently,

Indexed as

Antibodies, AntinuclearAntibodies, BacterialBiomarkersEnterococcusGastrointestinal MicrobiomeHumansImmunoglobulin AImmunoglobulin GIntestinesLupus Erythematosus, SystemicRetrospective StudiesAntibodies, AntinuclearAntibodies, BacterialBiomarkersImmunoglobulin AImmunoglobulin Ganti-RNAautoantibodiesbacterial antibodiesgut microbeslupusmicrobiomeribosomal P

Identifiers

PMID34122404
PMCPMC8193979
OpenAlexW3171916790

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.